- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06132022
The Effect of Mandala Application on Anxiety Level and Caregiver Burden in Palliative Care (MANDALAPLİC)
March 21, 2024 updated by: Necmiye ÇÖMLEKÇİ, Bartın Unıversity
The Effect of Mandala Application on Anxiety Level and Caregiver Burden in Palliative Caregivers: A Randomized Controlled Trial
The caregivers of palliative care patients can also be negatively affected during the palliative care process.
Especially family caregivers may experience difficulties in physical, social, economic, and psychological aspects.
Non-pharmacological approaches are utilized to cope with these difficulties.
The mandala study is one of the non-pharmacological approaches and has been utilized to support patients and caregivers in various illnesses.
Mandala is a method that anyone can apply, based on coloring circular patterns.
Recent studies have reported that mandala contributes to improving psychological and physiological well-being.
This study is designed in a randomized controlled design to examine the effects of mandala application on anxiety levels and caregiver burden in palliative care caregivers.
Caregivers who meet the inclusion and exclusion criteria will be randomly assigned to two groups using a computer program.
Both groups of caregivers will be administered an information form, the STAI XT-1 State-Trait Anxiety Inventory, and the Zarit Burden Interview Scale.
Then, the intervention group will be asked to apply mandala twice a week for 30 minutes for one month.
After one month, the scales will be administered again.
The caregivers in the control group will not receive any intervention, and after one month, the scales will be administered, and mandala application will be suggested.
According to G Power analysis, with a Type I error (α) of 0.05 and a power (1-β) of 0.80, the minimum sample size that will meet the requirements is determined to be a total of 86 individuals (experimental: 43, control: 43).
Considering potential sample loss, the aim is to reach 45 participants in each group.
The statistical analysis of the data will be performed using SPSS version 22.0.
Descriptive statistics such as frequency, median, standard deviation, mean, minimum, maximum, percentage, Kolmogorov-Smirnov test for normal distribution (N>30), skewness, and kurtosis will be used for sociodemographic characteristics.
Correlation tests will be used for scale relationships, and ANOVA, Kruskal-Wallis, t-test, or Mann-Whitney U test and post-hoc tests will be used for scale comparisons according to independent variables.
The significance level will be accepted as p<0.05.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
105
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kağıthane
-
Istanbul, Kağıthane, Turkey, 34000
- Istanbul Atlas University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- have reached the age of 18
- Willingness to participate in the study
- Being able to read and write
- Having no problems in verbal communication
- Providing free care
Exclusion Criteria:
- Providing paid care
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
The intervention group will be asked to practice the mandala twice a week, for 30 minutes, for a month.
At the end of one month, the scales will be applied again.
|
Mandala work is one of the non-pharmacological approaches and is used to support patients and caregivers in various diseases.
Mandala is a method that anyone can apply based on coloring a circular shape.
|
Placebo Comparator: Control group
Caregivers in the control group will not take any action, and at the end of one month, after the scales have been applied, they will be offered mandala applications.
|
The clinic's routine information will be given to the caregivers of the control group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
STAI XT-1 State-Trait Anxiety Scale
Time Frame: 4 weeks
|
score anxiety: While the state anxiety scale shows the level of anxiety in a certain situation, the trait anxiety scale evaluates the level of anxiety experienced by the individual regardless of the situation.
Scores on both scales range between 20 and 80. High scores indicate high anxiety level, low scores indicate low anxiety level.
|
4 weeks
|
Zarit Care Burden Scale
Time Frame: 4 weeks
|
Care Burden Scale: The scale, which can be completed by asking the caregivers themselves or the researcher, consists of 22 statements that determine the impact of caregiving on the individual's life.
With this, the caregiver/patient relationship, the caregiver's health status, psychological comfort, social life and economic burden can be evaluated.
The evaluation of scale, in which all items are clearly stated, is made on the basis of the total score.
As the score increases, the burden of care also increases and a maximum score of 88 is obtained from the scale.
Points obtained; It was evaluated by grading as (0-20) little/no burden, (21-40) moderate burden, (41-60) severe burden and (61-88) extreme burden.
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 15, 2023
Primary Completion (Actual)
February 15, 2024
Study Completion (Actual)
February 15, 2024
Study Registration Dates
First Submitted
May 30, 2023
First Submitted That Met QC Criteria
November 13, 2023
First Posted (Actual)
November 15, 2023
Study Record Updates
Last Update Posted (Actual)
March 22, 2024
Last Update Submitted That Met QC Criteria
March 21, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 27042
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The data will be stored in flash memory and shared with other researchers when necessary.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiRecruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)Active, not recruitingGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Nazife Begüm KARANCompletedDental Anxiety | Sedative; Anxiety DisorderTurkey
-
Loyola UniversityCompletedAnxiety | Anxiety State | Procedural AnxietyUnited States
-
Eli Lilly and CompanyCompletedAnxiety Neuroses | Anxiety States, Neurotic | Neuroses, AnxietyUnited States, Mexico, South Africa
-
West University of TimisoaraUnknownAnxiety Disorder/Anxiety StateRomania
-
Dr. Nazanin AlaviActive, not recruitingGeneralized Anxiety Disorder | AnxietyCanada
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States
Clinical Trials on Mandala
-
Marmara UniversityCompletedCoronary Artery Disease | AnxietyTurkey
-
Kırklareli UniversityNot yet recruiting
-
Kırklareli UniversityRecruiting
-
Kırklareli UniversityCukurova UniversityCompletedAnxiety | ClimactericumTurkey
-
Ege UniversityEnrolling by invitationChemotherapy-induced Nausea and Vomiting | Nursing CariesTurkey
-
Istanbul Sabahattin Zaim UniversityCompletedMental Health IssueTurkey
-
Bianca MasturzoNot yet recruiting"Sweet Expectation and Positive Thinking" the Use of the Mandala in the Induction of Labor (Mandala)Induction of Labor Affected Fetus / Newborn | Nulliparity
-
Sultan Abdulhamid Han Training and Research Hospital...RecruitingQuality of Life | Cancer | Fatigue | Chemotherapy Effect | Rumination | AlexithymiaTurkey
-
Istanbul Sabahattin Zaim UniversityCompleted
-
Ataturk UniversityRecruitingType-2 Diabetic Patients | Mandala PaintingTurkey